Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma

por Khunger, Arjun, Sarikonda, Ghanashyam, Tsau, Jennifer, Pahuja, Anil, Alfonso, Zeni, Gao, Jane, Laing, Christian, Vaupel, Christine, Dakappagari, Naveen, Tarhini, Ahmad A.
Publicado 2021

ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS

por Sallman, David A, Komrokji, Rami, Cluzeau, Thomas, Vaupel, Christine, Al Ali, Najla H, Lancet, Jeffrey, Hall, Jeff, List, Alan, Padron, Eric, Song, Jinming
Publicado 2017

MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC

por Franklin, Derek A., Sharick, Joe T., Ericsson-Gonzalez, Paula I., Sanchez, Violeta, Dean, Phillip T., Opalenik, Susan R., Cairo, Stefano, Judde, Jean-Gabriel, Lewis, Michael T., Chang, Jenny C., Sanders, Melinda E., Cook, Rebecca S., Skala, Melissa C., Bordeaux, Jennifer, Orozco Bender, Jehovana, Vaupel, Christine, Geiss, Gary, Hinerfeld, Douglas, Balko, Justin M.
Publicado 2020

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma

por Shiuan, Eileen, Reddy, Anupama, Dudzinski, Stephanie O., Lim, Aaron R., Sugiura, Ayaka, Hongo, Rachel, Young, Kirsten, Liu, Xian-De, Smith, Christof C., O’Neal, Jamye, Dahlman, Kimberly B., McAlister, Renee, Chen, Beiru, Ruma, Kristen, Roscoe, Nathan, Bender, Jehovana, Ward, Joolz, Kim, Ju Young, Vaupel, Christine, Bordeaux, Jennifer, Ganesan, Shridar, Mayer, Tina M., Riedlinger, Gregory M., Vincent, Benjamin G., Davis, Nancy B., Haake, Scott M., Rathmell, Jeffrey C., Jonasch, Eric, Rini, Brian I., Rathmell, W. Kimryn, Beckermann, Kathryn E.
Publicado 2021